Abstract:A series of novel chalcone analogs derived from syringaldehyde have been synthesized through acid or base-catalyzed aldol condensation. The anticancer activity of the newly synthesized compounds was assessed against a range of women-specific cancer cell lines, including A2780 (ovarian cancer), HeLa and C33a (cervical cancer), and MDA-MB-453, MDA-MB-231 and MCF-7 (breast cancer). The majority of these compounds demonstrated remarkable cytotoxicity against the tested cancer cells. Compound 2a displayed the most promising anti-proliferation activity against the selected female cancer cells, while also exhibiting the weakest cytotoxicity towards human normal cells. Therefore, it was chosen as the active compound based on both drug efficacy and safety considerations in this study. The findings indicated that compound 2a induced cell apoptosis and G2/M phase arrest by causing significant DNA damage and provoking a strong DNA damage response. Moreover, the results indicated that compound 2a affected the phosphorylation and distribution of FAK, thereby inhibiting cell adhesion and migration. Furthermore, compound 2a exhibited excellent potential in inhibiting A2780-derived xenograft tumor growth in mice, without any impact on their body weight. Tissue distribution experiments indicated that compound 2a tended to accumulate in the ovary in vivo. Overall, these results suggest that compound 2a may serve as a promising lead compound for developing anticancer agents against female cancer, especially in the case of ovarian cancer treatment.

Chiral Gossypol Derivatives: Evaluation of Their Anticancer Activity and Molecular Modeling.

Synthesis, biological evaluation and mechanism study of chalcone analogues as novel anti-cancer agents

Syntheses and Anticancer Activities of Glycine Derivatives of Chrysin

Synthesis, Molecular Modeling and Biological Evaluation of Chalcone Thiosemicarbazide Derivatives As Novel Anticancer Agents.

Synthesis and Biological Evaluation of Novel Spin Labeled 18Β-Glycyrrhetinic Acid Derivatives

Recent progress in gossypol derivatives and their structure-activity relationship

Gossypol with Hydrophobic Linear Esters Exhibits Enhanced Antitumor Activity As an Inhibitor of Antiapoptotic Proteins.

Synthesis, Biological Evaluation and Docking Studies of (E)-3-Aryl-2-(3,4,5-trimethoxybenzoyl) Acrylonitrile Derivatives as Anticancer Agents

Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors.

Natural Product Gossypol and Its Derivatives in Precision Cancer Medicine

Synthesis and Evaluation of Antitumor Activities of Novel Chiral 1,2,4-Triazole Schiff Bases Bearing Γ-Butenolide Moiety

Design, Synthesis and Evaluation of Structurally Diverse Chrysin-Chromene-spirooxindole Hybrids As Anticancer Agents.

Synthesis and evaluation of some new aza-B-homocholestane derivatives as anticancer agents.

Novel Alpha, Beta-Unsaturated Sophoridinic Derivatives: Design, Synthesis, Molecular Docking And Anti-Cancer Activities

A Novel Water-Soluble Gossypol Derivative Increases Chemotherapeutic Sensitivity and Promotes Growth Inhibition in Colon Cancer

Synthesis and Anti-Tumor Evaluation of Novel C-37 Modified Derivatives of Gambogic Acid

Studies on Chemical Structure Modification and Structure?Activity Relationship of Derivatives of Gambogic Acid at C(39)

Synthesis and Evaluation of Novel Isoxazolyl Chalcones As Potential Anticancer Agents.

Synthesis, characterization, and anticancer activity of syringaldehyde-derived chalcones against female cancers

Synthesis and Anticancer Activity Evaluation of some Curcumol Derivatives

Rational Synthesis and Preliminary Anti-cancer Activities of 18Β-Glycyrrhetinic Acid Derivatives Containing Pyridinecarboxamide